Team of Stock Traders

$KLDO, what a run? Asked to buy at $.16 and hold overnight - today's high $.50< solid 202% gaining range 🔥🥳solid alert 🎉Alert & Technical Analysis goes through “Telegram Messenger” Get your day trader’s membership to join us 🥳 teamofstocktraders.com
 #StocksToBuy #stock

House of Representatives Approves Department of Homeland Security Appropriations Act with Focus on Alternative to Detention Program and GPS Monitoring beststocks.com/house-of-repre…

Cathie Wood Says SEC Will Approve Multiple Bitcoin ETFs at Once: BBG

🛢️Oil drops below $75 per barrel as weak China growth data spurs demand concerns

Coinbase shares are trading lower after the SEC sued Binance over US securities violations.

@madaznfootballr Are you usually Interactive Broker Pro?

Was long about 31ish average 5Kish shares. Out most around 42ish as high as 47. Fills weren't the best but FUCKING AWESOME $CXAI

#Dogecoin to $1 Dollar - that’s the tweet

@ProTheDoge Let’s hit $1 💵 @ProTheDoge

1/4 of my #Dogecoin is still in #Robinhood lol 😂🚀 not too shabby 🤷🏼‍♂️

@ProTheDoge You have been holding for nearly two years 😤 not selling until we hit the dollar 💵 a dollar bill

#Dogecoin will still reach $1 dollar

@ProTheDoge Hell ya

Breaking: A group of 11 banks have agreed to deposit $30 billion into $FRC to help stabilize the bank, with $JPM, $BAC, $C, and $WFC contributing $5 billion each. finance.yahoo.com

Natural Gas Prices Rebound After Dipping Below $2 -- Market Talk

Clearwater Analytics Holdings (CWAN) has an average outperform rating and a price target range of $14 to $25, according to analysts polled by Capital IQ.

Expeditors International of Washington (EXPD) has an average underperform rating and a price target range of $90 to $120, according to analysts polled by Capital IQ.

Sage Therapeutics (SAGE) said Wednesday it received the Orphan drug designation from the European Medicines Agency for its Huntington's disease treatment candidate, Sage-718.

$AZN - AstraZeneca Says European Commission Approvals Secured for Cancer Treatments

$GMAB - Genmab Announces Initiation of Share Buy-Back Program

$APLS - Apellis Pharmaceuticals Launches $300 Million Securities Offering; Shares Higher

Applied Materials (AMAT) has an average outperform rating and price target range of $90 to $150, according to analysts polled by Capital IQ.

Focus Financial Partners (FOCS) seems to be trading more on technical factors than fundamentals and there's a lack of clarity on the $53 per share offer from Clayton, Dubilier & Rice, Oppenheimer said in a note on Friday.

DigitalOcean Holdings (DOCN) has an average outperform rating and price target range of $30 to $63, according to analysts polled by Capital IQ.